CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 126	$ 315
Accounts receivable, net of allowance for credit losses of $28 and $30 as of June 30, 2023 and December 31, 2022, respectively	1,235	1,195
Inventories	184	192
Prepaid expenses and other current assets	188	196
Total current assets	1,733	1,898
Property, plant and equipment, net	1,814	1,766
Operating lease right-of-use assets	611	585
Goodwill	7,733	7,220
Intangible assets, net	1,247	1,092
Investments in equity method investees	135	132
Other assets	152	144
Total assets	13,425	12,837
Liabilities and Stockholders' Equity
Accounts payable and accrued expenses	1,201	1,396
Current portion of long-term debt	518	2
Current portion of long-term operating lease liabilities	156	153
Total current liabilities	1,875	1,551
Long-term debt	3,777	3,978
Long-term operating lease liabilities	508	489
Other liabilities	901	812
Commitments and contingencies
Redeemable noncontrolling interest	77	77
Quest Diagnostics stockholders’ equity:
Common stock, par value $0.01 per share; 600 shares authorized as of both June 30, 2023 and December 31, 2022; 162 shares issued as of both June 30, 2023 and December 31, 2022	2	2
Additional paid-in capital	2,284	2,295
Retained earnings	8,566	8,290
Accumulated other comprehensive loss	(16)	(21)
Treasury stock, at cost; 50 and 51 shares as of June 30, 2023 and December 31, 2022, respectively	(4,587)	(4,673)
Total Quest Diagnostics stockholders' equity	6,249	5,893
Noncontrolling interests	38	37
Total stockholders' equity	6,287	5,930
Total liabilities and stockholders' equity	$ 13,425	$ 12,837